ReAct’s new 5-year strategic plan receives funding from Sida

For many years, ReAct has focused on driving the issue of antibiotic resistance up the global political agenda. Today global political awareness about antibiotic resistance has reached unprecedented levels. ReAct will therefore now tackle the next challenge: to ensure that global action meets the actual needs, in particular in low- and middle-income countries. To address this objective, ReAct will focus on four strategic areas in the coming five years, with continued core funding from Sida.

Anna Zorzet, Head of ReAct Europe says:
"We are very grateful and motivated. This renewed funding from Sida gives us the opportunity to continue our work on antibiotic resistance, both with a global and local perspective. Awareness and actions on antibiotic resistance are on the rise, but there is still much to do. With this long-term support from Sida we can continue to address antibiotic resistance.”

Sida a long-term funder

Since its inception in 2005, ReAct’s main funder has been the Swedish International Development Cooperation Agency (Sida). The renewed core funding from Sida is for the period 2019-2022 and will be used to maintain the work of the network and its activities under the new strategic plan. ReAct receives 72 million SEK in funding for 4 years.

Low resource settings in focus

The world’s collective response to antibiotic resistance will only be as strong as the weakest healthcare delivery and food production system will allow. This is why it is crucial that solutions are sustainable and workable also in resource limited contexts, countries and populations. ReAct works to ensure that this reality is presented and understood at all political levels. Through all four of ReAct’s new strategic objectives the efforts will be done with the lens of low and middle-income countries’ settings.

The four objectives that will guide ReAct’s work in the next five years are:

• National action plans
• Movement building
• Globally coordinated governance
• Public health driven innovation

About ReAct

Created in 2005 by Professor Otto Cars, Uppsala University, ReAct is one of the first international independent networks to articulate the complex nature of antibiotic resistance and its drivers. ReAct was initiated with the goal to be a global catalyst, advocating and stimulating for global engagement on antibiotic resistance by collaborating with a broad range of organisations, individuals and stakeholders.ReAct was started , and has since grown and is now on five continents.
Read more about ReAct.